Predictive biomarkers in radioresistant rectal cancer: A systematic review

Anna Slipsager; Sofie N. Henrichsen; Ursula G. Falkmer; Karen Dybkær; Mattias Belting; Laurids Poulsen

doi:10.1016/j.critrevonc.2023.103991

Predictive biomarkers in radioresistant rectal cancer: A systematic review

Anna Slipsager, Sofie N. Henrichsen, Ursula G. Falkmer, Karen Dybkær, Mattias Belting, Laurids Poulsen

Research output: Contribution to journal › Review article › peer-review

Abstract

Background and aims: The treatment of locally advanced rectal cancer often consists of neoadjuvant chemoradiotherapy followed by surgery. However, approximately 15% of patients show no response to this neoadjuvant chemoradiotherapy. This systematic review aimed to identify biomarkers of innate radioresistant rectal cancer. Method: Through a systematic literature search, 125 papers were included and analyzed using ROBINS-I, a Cochrane risk of bias tool for non-randomized studies of interventions. Both statistically significant and nonsignificant biomarkers were identified. Biomarkers mentioned more than once in the results or biomarkers with a low or moderate risk of bias were included as the final results. Results: Thirteen unique biomarkers, three genetic signatures, one specific pathway, and two combinations of two or four biomarkers were identified. In particular, the connection between HMGCS2, COASY, and PI3K-pathway seems promising. Future scientific research should focus on further validating these genetic resistance markers.

Original language	English
Article number	103991
Journal	Critical Reviews in Oncology/Hematology
Volume	186
DOIs	https://doi.org/10.1016/j.critrevonc.2023.103991
Publication status	Published - 2023

Subject classification (UKÄ)

Cancer and Oncology

Free keywords

Molecular biomarker
Neoadjuvant therapy
Radiotherapy
Rectal Neoplasms
Resistance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.critrevonc.2023.103991

Cite this

@article{095250d073d24220afe9913669d23de4,

title = "Predictive biomarkers in radioresistant rectal cancer: A systematic review",

abstract = "Background and aims: The treatment of locally advanced rectal cancer often consists of neoadjuvant chemoradiotherapy followed by surgery. However, approximately 15% of patients show no response to this neoadjuvant chemoradiotherapy. This systematic review aimed to identify biomarkers of innate radioresistant rectal cancer. Method: Through a systematic literature search, 125 papers were included and analyzed using ROBINS-I, a Cochrane risk of bias tool for non-randomized studies of interventions. Both statistically significant and nonsignificant biomarkers were identified. Biomarkers mentioned more than once in the results or biomarkers with a low or moderate risk of bias were included as the final results. Results: Thirteen unique biomarkers, three genetic signatures, one specific pathway, and two combinations of two or four biomarkers were identified. In particular, the connection between HMGCS2, COASY, and PI3K-pathway seems promising. Future scientific research should focus on further validating these genetic resistance markers.",

keywords = "Molecular biomarker, Neoadjuvant therapy, Radiotherapy, Rectal Neoplasms, Resistance",

author = "Anna Slipsager and Henrichsen, {Sofie N.} and Falkmer, {Ursula G.} and Karen Dybk{\ae}r and Mattias Belting and Laurids Poulsen",

year = "2023",

doi = "10.1016/j.critrevonc.2023.103991",

language = "English",

volume = "186",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier",

}

TY - JOUR

T1 - Predictive biomarkers in radioresistant rectal cancer

T2 - A systematic review

AU - Slipsager, Anna

AU - Henrichsen, Sofie N.

AU - Falkmer, Ursula G.

AU - Dybkær, Karen

AU - Belting, Mattias

AU - Poulsen, Laurids

PY - 2023

Y1 - 2023

N2 - Background and aims: The treatment of locally advanced rectal cancer often consists of neoadjuvant chemoradiotherapy followed by surgery. However, approximately 15% of patients show no response to this neoadjuvant chemoradiotherapy. This systematic review aimed to identify biomarkers of innate radioresistant rectal cancer. Method: Through a systematic literature search, 125 papers were included and analyzed using ROBINS-I, a Cochrane risk of bias tool for non-randomized studies of interventions. Both statistically significant and nonsignificant biomarkers were identified. Biomarkers mentioned more than once in the results or biomarkers with a low or moderate risk of bias were included as the final results. Results: Thirteen unique biomarkers, three genetic signatures, one specific pathway, and two combinations of two or four biomarkers were identified. In particular, the connection between HMGCS2, COASY, and PI3K-pathway seems promising. Future scientific research should focus on further validating these genetic resistance markers.

AB - Background and aims: The treatment of locally advanced rectal cancer often consists of neoadjuvant chemoradiotherapy followed by surgery. However, approximately 15% of patients show no response to this neoadjuvant chemoradiotherapy. This systematic review aimed to identify biomarkers of innate radioresistant rectal cancer. Method: Through a systematic literature search, 125 papers were included and analyzed using ROBINS-I, a Cochrane risk of bias tool for non-randomized studies of interventions. Both statistically significant and nonsignificant biomarkers were identified. Biomarkers mentioned more than once in the results or biomarkers with a low or moderate risk of bias were included as the final results. Results: Thirteen unique biomarkers, three genetic signatures, one specific pathway, and two combinations of two or four biomarkers were identified. In particular, the connection between HMGCS2, COASY, and PI3K-pathway seems promising. Future scientific research should focus on further validating these genetic resistance markers.

KW - Molecular biomarker

KW - Neoadjuvant therapy

KW - Radiotherapy

KW - Rectal Neoplasms

KW - Resistance

U2 - 10.1016/j.critrevonc.2023.103991

DO - 10.1016/j.critrevonc.2023.103991

M3 - Review article

C2 - 37059272

AN - SCOPUS:85152905259

SN - 1040-8428

VL - 186

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

M1 - 103991

ER -

Predictive biomarkers in radioresistant rectal cancer: A systematic review

Abstract

Subject classification (UKÄ)

Free keywords

UN SDGs

Access to Document

Fingerprint

Cite this